Comparative Genomics Revealed Genetic Diversity and Species/Strain-Level Differences in Carbohydrate Metabolism of Three Probiotic Bifidobacterial Species

Abstract

Strains of Bifidobacterium longum, Bifidobacterium breve, and Bifidobacterium animalis are widely used as probiotics in the food industry. Although numerous studies have revealed the properties and functionality of these strains, it is uncertain whether these characteristics are species common or strain specific. To address this issue, we performed a comparative genomic analysis of 49 strains belonging to these three bifidobacterial species to describe their genetic diversity and to evaluate species-level differences. There were 166 common clusters between strains of B. breve and B. longum, whereas there were nine common clusters between strains of B. animalis and B. longum and four common clusters between strains of B. animalis and B. breve. Further analysis focused on carbohydrate metabolism revealed the existence of certain strain-dependent genes, such as those encoding enzymes for host glycan utilisation or certain membrane transporters, and many genes commonly distributed at the species level, as was previously reported in studies with limited strains. As B. longum and B. breve are human-residential bifidobacteria (HRB), whereas B. animalis is a non-HRB species, several of the differences in these species' gene distributions might be the result of their adaptations to the nutrient environment. This information may aid both in selecting probiotic candidates and in understanding their potential function as probiotics.

Host-derived glycans serve as selected nutrients for the gut microbe: human milk oligosaccharides and bifidobacteria†

“…The metabolic process of LNB inside the cells has been summarized by Kitaoka. 65) The limited occurrence of the homologs of HMO-degrading enzymes in bifidobacteria has also been reported by Odamaki et al 66)…”

The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies

“…It is essential that great care be taken to use actual bacterial isolates that have the desired biological properties, which will necessitate focusing beyond the species and down to the strain level. A panel of cultured Bifidobacterium and E. hirae species and strains showed major distinctions based on genome sequencing, and clearly not all strains will be efficacious in vivo (16,34). Once specific bacteria candidates are identified, then a final challenge would be to use preclinical systems for functional screening.…”

A Human Gut Commensal Ferments Cranberry Carbohydrates To Produce Formate

“…The B. longum subsp. longum genome, for example, encodes a large number of GHs dedicated to arabinose and xylose utilization (14). In contrast, the chromosome of the phylogenetic near neighbor and infant-colonizing bacterium B. longum subsp.…”